共 354 条
[1]
Quint JK(2016)Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study Eur Respir J 47 186-193
[2]
Millett ERC(2015)Hospital admissions for non-cystic fibrosis bronchiectasis in New Zealand N Z Med J 128 30-38
[3]
Joshi M(2013)Bronchiectasis-associated hospitalizations in Germany, 2005–2011: a population-based study of disease burden and trends PLoS ONE 8 e71109-439
[4]
Navaratnam V(2012)Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007 Chest 142 432-209
[5]
Thomas SL(2005)Prevalence and economic burden of bronchiectasis Clin Pulm Med 12 205-890
[6]
Hurst JR(2018)Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity Lancet 392 880-1022
[7]
Smeeth L(2018)Bronchiectasis: Treatment decisions for pulmonary exacerbations and their prevention: pulmonary exacerbations in bronchiectasis Respirology 23 1006-726
[8]
Brown JS(2018)Bronchiectasis: new therapies and new perspectives Lancet Respir Med 6 715-297
[9]
Bibby S(2014)The evidence base for non-CF bronchiectasis is finally evolving Respirology 19 295-485
[10]
Milne R(2000)Tobramycin solution for inhalation reduces sputum Am J Respir Crit Care Med 162 481-749